GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

The Global Antibiotic Research & Development Partnership (GARDP) and Penta, the paediatric infectious diseases research network, have joined forces to tackle drug-resistant infections in children. The strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements; and trials with a focus on public health interventions to inform treatment guidelines.

Article: GARDP

Smart Innovations  
Back


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed